Health Condition 1: I080- Rheumatic disorders of both mitraland aortic valves
Conditions
Interventions
Intervention1: Inj. Sugammadex 2 mg/kg Intravenously, administered once.: Neuromuscular blockage reversal after surgery using 2 mg/kg drug once, intravenously after return of TOF count 2 twitches af
Sponsors
Institutional Research Society
Eligibility
Inclusion criteria
Inclusion criteria: American Society of Anaesthesiologist (ASA) physical status II - III undergoing elective open heart surgeries under general anaesthesia, and requiring rocuronium-induced neuromuscular blockade will be included in the study. This includes patients undergoing - 1. Aortic valve replacement 2. Mitral valve replacement 3. Atrial septal defect closure 4. Ventricular septal defect closure
Exclusion criteria
Exclusion criteria: Aortic cross clamp time more than 100 minutes Difficulty in weaning from cardiopulmonary bypass despite adequate inotropic support Patients with preexisting DM, thyroid disorders and neuromuscular disorders Postoperative hemodynamic instability making patient not suitable for weaning from ventilator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to extubation in post anesthesia care unit, which is the time in minutes from procedure stop to the time of extubationTimepoint: Upto 6 hours after surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| Respiratory parameters after surgery Delirium in the postoperative care unit Time to return of bowel sounds after surgery Time to first ambulation Time to discharge from ICUTimepoint: Upto 12 hours after surgery | — |
Countries
India
Contacts
Public ContactDr Sanjeeta Umbarkar
Seth GS medical college and KEM hospital, MUMBAI
Outcome results
None listed